Novo Integrated Sciences, Inc. - Common Stock (NQ:NVOS)

0.1490 UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novo Integrated Sciences, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Novo Integrated Sciences Enters into Purchase Agreement to Acquire Clinical Consultants International LLC

March 23, 2022

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences to Participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest

March 16, 2022

From Novo Integrated Sciences, Inc. Novo Integrated Sciences, Inc.

Via Business Wire

Multidisciplinary Nasdaq Listed Healthcare Provider Growing via Multiple High Value Acquisitions: Novo Integrated Sciences, Inc. (NASDAQ: NVOS)

October 19, 2021

Via Viz Release

Novo Integrated Sciences’ IoNovo for Kids Pure Iodine Oral Spray Granted Natural Product Number (NPN) by Health Canada

February 18, 2022

From Novo Integrated Sciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 26, 2022

Gainers Rani Therapeutics Hldgs (NASDAQ:RANI

Via Benzinga

Novo Integrated Sciences Reports First Quarter Financial Results

January 18, 2022

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Announces the Signing of a Master Facility License Agreement with LA Fitness in Canada

January 14, 2022

From Novo Integrated Sciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 04, 2022

Gainers Oncternal Therapeutics (NASDAQ:ONCT

Via Benzinga

Novo Integrated Sciences Granted Natural Product Number (NPN) by Health Canada for IoNovo Iodine Branded Product

December 23, 2021

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Reports Fiscal Full Year 2021 Financial Results

December 14, 2021

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Acquires Majority Stake in Terragenx ↗

November 30, 2021

Novo Integrated Sciences Inc (NASDAQ: NVOS) has acquired 91% of Terragenx through an all-share transaction at $3.35 per share. The human immune system...

Via Benzinga

Novo Integrated Sciences Acquires Majority Stake in Terragenx and Intellectual Property for FDA and Health Canada Approved Water-Soluble Iodine Micro-Nutrient

November 30, 2021

From Novo Integrated Sciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 22, 2021

Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 95.32% to $9.61 during Monday's regular session. Trading volume for iSpecimen's stock is 70.9 million as of...

Via Benzinga

Novo Integrated Sciences (NASDAQ: NVOS) Just Announced a Partnership That Could Shake Up the Telehealth Sector ↗

October 28, 2021

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Novo Integrated...

Via Benzinga

Novo Integrated Sciences’ subsidiary, Novo Healthnet Limited, and EK-Tech Solutions Announce Joint Venture for Enhanced Telehealth Platform

October 14, 2021

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Signs LOIs to Acquire 7 Pharmacies in the US ↗

October 13, 2021

Image provided by Tbel Abuseridze on Unsplash Novo Integrated Sciences, Inc. (NASDAQ: NVOS), a pioneer in holistic, patient-first health and wellness services and products, has...

Via Benzinga

Multidisciplinary Nasdaq Listed Healthcare Provider Growing via Multiple High Value Acquisitions: Novo Integrated Sciences, Inc. (NASDAQ: NVOS)

October 04, 2021

Via Get News

22 Stocks Moving in Friday's Pre-Market Session ↗

September 24, 2021

Gainers Focus Universal Inc. (NASDAQ: FCUV) rose 42% to $15.24 in pre-market trading. The company’s shares jumped around 65% over the previous month. vTv Therapeutics Inc...

Via Benzinga

Novo Integrated Sciences to Present at the Benzinga Virtual Global Healthcare Small Cap Conference on September 30th

September 23, 2021

From Novo Integrated Sciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

September 15, 2021

Gainers Larimar Therapeutics (NASDAQ:

Via Benzinga

Novo Integrated Sciences Signs LOIs to Acquire Seven Pharmacies in the United States

August 30, 2021

From Novo Integrated Sciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 23, 2021

Gainers Cara Therapeutics (NASDAQ:CARA) ...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 18, 2021

Gainers PharmaCyte Biotech (NASDAQ:PMCB) shares rose 71.92% to $5.88 during Wednesday's pre-market session. The market value of their outstanding shares is at $9.4...

Via Benzinga

Novo Integrated Sciences’ Subsidiary, Acenzia, Signs Exclusive Licensing Agreement with Performance Inspired Nutrition to Manufacture and Distribute in the Middle East

August 18, 2021

From Novo Integrated Sciences, Inc.

Via Business Wire

Novo Integrated Sciences Launches New Patient Portal App Giving Patients More Control Over Their Healthcare ↗

August 11, 2021

The ‘new’ reality of the COVID-19 pandemic, ongoing advancements in medical technology, inter-connectivity, and blockchain technology, are all key drivers in the...

Via Benzinga

60 Biggest Movers From Yesterday ↗

August 17, 2021

Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 33.7% to close at $3.37 on Monday after the company announced plan to expand product portfolio with introduction of...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 06, 2021

Gainers Nuwellis (NASDAQ:NUWE) shares in...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 15, 2021

Gainers Akebia Therapeutics (NASDAQ:AKBA...

Via Benzinga

Novo Integrated Sciences' Patented Zgraft Platform can Predict Cancer Progression and Treatment Outcomes ↗

July 15, 2021

Image Provided By Pexels Novo Integrated Sciences Inc. (NASDAQ: NVOS), a pioneer in developing patient-centric care through advanced therapeutics and technology, recently acquired...

Via Benzinga

Novo Integrated Sciences Announces Third Quarter 2021 Financial Results

July 14, 2021

From Novo Integrated Sciences, Inc.

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.